OverviewChartNewsTraderScreen

BVT Call 230 BIIB 17.05.2024/  DE000VD1GZV7  /

EUWAX
2024-05-03  8:55:07 AM Chg.-0.078 Bid7:39:01 PM Ask7:39:01 PM Underlying Strike price Expiration date Option type
0.098EUR -44.32% 0.116
Bid Size: 62,000		 0.137
Ask Size: 62,000		 Biogen Inc 230.00 USD 2024-05-17 Call
GlobeNewswire 05-02 Biogen Reports Progress on Corporate Responsibility Priorities
GlobeNewswire 04-29 Muscular Dystrophy Association Launches ALS Awareness Month with Public Service Announcement ‘Answer...
GlobeNewswire 04-25 Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEM...
TeleTrader 04-24 US closes mixed with earnings in limelight
TeleTrader 04-24 Biogen posts Q1 revenue of $2.3 billion
TeleTrader 04-24 US mostly up premarket with earnings in focus
GlobeNewswire 04-23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
TeleTrader 04-21 Weekly Preview: Key earnings reports expected
GlobeNewswire 04-17 Unispace Group announces new EMEA CEO appointment
GlobeNewswire 04-15 Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
GlobeNewswire 04-10 Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
GlobeNewswire 04-02 ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer
GlobeNewswire 04-02 Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
GlobeNewswire 04-01 Autolus Therapeutics Announces Changes to its Board of Directors
GlobeNewswire 03-25 Dyne Therapeutics Announces CEO Transition
GlobeNewswire 03-13 Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
GlobeNewswire 03-11 Hyku Biosciences, a Covalent Precision Medicine Company, Announces CEO Transition for its Next Phase...
GlobeNewswire 03-08 From the Beach to the Boardroom: Unispace's 'Art for Impact' Program Partners with NGO to Turn 50,00...
GlobeNewswire 03-07 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. - BI...
GlobeNewswire 03-06 New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) i...
GlobeNewswire 03-06 Genesis Research Group Announces Appointment of David W. Miller as CEO
GlobeNewswire 03-04 Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (...
GlobeNewswire 02-28 Promising Pathways to Simplified Alzheimer's Diagnosis Unveiled in Groundbreaking Study
GlobeNewswire 02-27 Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlig...
GlobeNewswire 02-27 Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024